Dokta Tho Lye Mun Oncology

Dr. Tho Lye Mun yana daya daga cikin manyan likitocin cutar kanjamau a Kuala Lumpur Malaysia.

Dr Tho Lye Mun ya kammala karatun digiri na farko da na biyu a Australia da United Kingdom a karkashin shirye-shiryen tallafin karatu na kasashen waje. Ya cancanta a cikin Magungunan Cikin Gida (MRCP) kuma yana riƙe da Fellowship na Royal College of Radiologists UK a Clinical Oncology (FRCR) da kuma cikakken ƙwararren ƙwararren Burtaniya. Daga nan sai ya ci gaba da neman aikin likitancin likitanci inda ya samu digirin digirgir a fannin ilmin kwayoyin halitta a karkashin babbar manhajar CRUK/RCR wadda aka ba shi kyaututtuka daban-daban da suka hada da John Paul Award da Medal Anne Hollman. Ya yi aiki a matsayin Mataimakin Farfesa a Jami'ar Malaya kafin ya koma aiki na sirri.

A halin yanzu Dr Tho shine Mataimakin Shugaban SEAROG (Rukunin Radiation Oncology na Kudu maso Gabashin Asiya) kuma yana aiki don haɓaka dabarun haɓakar radiyo misali. SRS, SBRT/SABR. Shi ne kuma mataimakin shugaban LCNM (Lang Cancer Network na Malaysia). Dr. Shi mai magana ne da ake gayyata akai-akai a yanki da kuma na duniya.
Lambobin Yabo

1. John Paul Award, Mafi kyawun ɗaliban PhD, Burtaniya
2. Medal Anne Holman, Ƙungiyar Radiyo ta Scotland, Birtaniya
3. Cibiyar Nazarin Ciwon daji, Binciken Ciwon daji UK (CRUK) / Royal College of Radiologists, UK
4. Mafi kyawun Takarda, Taron Kimiyya na Shekara-shekara, Kwalejin Sarauta ta Ma'aikatan Radiyo, UK
5. Cibiyar Nazarin Ciwon daji, Cibiyar Nazarin Ciwon daji ta Beatson, Birtaniya
6. John Crawford Scholarship na Medicine, Ostiraliya
7. ASEAN Scholarship, Singapore

• wuka Gamma da Cyberknife SRS
• Intracranial Stereotactic Radiosurgery (SRS)
• Sashin Lafiya ta Jiki (SBRT)
• Stereotactic Ablative Jiki Radiotherapy (SABR)
• Nauyin Yanayin Rediyon Lafiya (IMRT)
• Maganin Radiyon Hoto (IGRT)

huhu Cancer. Oktoba 2019; 136:65-73.

Gwajin kwayoyin halitta don ci gaba da ciwon huhu na huhu a cikin Malesiya: Bayanin yarjejeniya daga College of Pathologists, Academy of Medicine Malaysia, Malaysian Thoracic Society, da Malaysian Oncological Society. Rajadurai P, Cheah PL, Yaya SH, Liam CK, Annuar MAA, Omar N, Othman N, Marzuki NM, Pang YK, Bustamam RSA, Ku LM.

Lancet. 2019 May 4;393(10183):1819-1830.

Pembrolizumab tare da chemotherapy don a baya ba a kula da su ba, PD-L1-bayyana, ci gaba a cikin gida ko ciwon huhu mara ƙananan ƙwayoyin cuta (KEYNOTE-042): bazuwar, lakabin buɗaɗɗe, sarrafawa, gwajin lokaci na 3. Mok et al KEYNOTE-042 Masu bincike.

Maganin ciwon daji. 2015 Aug;4(8):1196-204.

Ayyuka na yanzu a cikin kula da ciwon daji a Asiya: binciken marasa lafiya da likitoci a cikin kasashe 10. ACHEON Working Group, Kim YC, Ahn JS, Calimag MM, Chao TC, Ho KY, Ta LM, Xia ZJ, Ward L, Moon H, Bhagat A.

Jaridar Asiya Pacific na Ciwon daji Prev. 2015;16(5):1901-6.

Abubuwan haɓakawa a cikin marasa lafiya tare da ƙananan ƙwayar cutar huhu da ƙananan ƙwayoyin cuta: hangen nesa na Malaysia. Tang WH, Alip A, Saad M, Phua VC, Chandran H, Tan YH, Tan YY, Kua VF, Wahid MI, Ku LM.

Ciwon daji na BMC. 2014 Maris 20; 14:212

Rufe rarrabuwar kawuna a duniya - ayyukan kula da cutar kansar nono a cikin ƙasa mai matsakaicin samun kudin shiga. Lim GC, Aina EN, Cheah SK, Ismail F, Ho GF, Ku LM, Yip Chet al HPMRS Ƙungiyar Nazarin Ciwon Kankara.

Maganin Niyya da Immunotherapy don Ciwon huhu

www.thestar.com.my/news/nation/2017/11/20/targeted-therapy-and-immunotherapy-for-lung-cancer

Haɓaka Tsarin Kariyar Mu don Yaƙar Ciwon daji

https://www.star2.com/health/2018/09/05/boosting-immune-system-treat-tumours

Bayyana Halin Halittar Dan Adam

https://www.nst.com.my/lifestyle/heal/2019/09/520171/profiling-human-genome

Fuskantar Ciwon Kansa Na Nono

https://www.nst.com.my/lifestyle/heal/2019/10/526132/facing-cancer